(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	23.99
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency

February 05, 2017

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the submission of a Marketing Authorization Application (MAA) for its investigational oral anaplastic lymphoma kinase (ALK) inhibitor,...

Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.

February 16, 2017

Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) (“ARIAD”) for $24.00 per share in cash.

Performance

More News

Ariad Pharmaceuticals (ARIA) Flat with Quarterly Loss Projected

April 12, 2017

?SEC charges two former Ariad executives with insider trading

June 27, 2017

Tesaro, AstraZeneca Could Shrink Clovis' Ovarian Cancer Drug Pool

January 30, 2017

Deadline Upcoming in $3.5 Million Settlement in the Ariad Pharmaceuticals Inc (NASDAQ:ARIA) Investor Lawsuit

April 25, 2018

3 Monster Biotech Stocks in the Making

September 24, 2017

XBI, JPNL: Big ETF Outflows

February 22, 2017

Immune Pharma To Unlock Value And Create Two Separate Pure Play Companies; Cytovia, Immune

July 11, 2017

XBI, UGE: Big ETF Outflows

February 14, 2017

Biotechnology: Poised To Head Higher

February 18, 2017

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.